$1M is traction.
$10M is team execution.

Most healthcare-tech and RCM services companies don't break because nobody wants the solution. They stall in the valley from startup to $10M, when deals get political, expensive, and too dependent on the founder to move.

Three operating cycles

Healthcare and staffing vertical software. Enterprise infrastructure software. Healthcare RCM services. I have carried a bag, sold into executives, built through the dot-com wreckage and the 2008 financial crisis, and co-founded, scaled, and exited a national healthcare revenue cycle company.

The work comes from operating where mistakes cost money, trust, and time.

Free field guide

The Hopeline Audit

How to find the deals that are lying to you.

A focused field guide for pressure-testing stalled, inflated, or founder-dependent opportunities before the forecast exposes what the pipeline has been hiding.

The 7 questions you need answered before a deal belongs in the pipeline.
Download the free audit
A Field Guide · Barone Advisory
The Hopeline Audit
How to find the deals that are lying to you.
Tim Barone · timothybarone.com
About Tim

I know where healthcare-tech and services revenue systems break because I’ve built inside them.

I'm Tim Barone. Three operating cycles taught me where the cliffs are: healthcare and staffing vertical software, enterprise infrastructure software, and co-founding, scaling, and exiting a national healthcare RCM company.

I came out of operating, not consulting. I have sold complex B2B software and services since I was 20 years old.

Read more about Tim →
Private advisory

I also do private advisory work.

For healthcare-tech, AI, and RCM services founders who have traction, but the sales motion is still too dependent on founder judgment. The Mercury Pressure Test is a focused diagnostic engagement built to surface what the forecast, pipeline, and founder-led motion are hiding.

See the Mercury Pressure Test

The Monday Memo.
Every Monday morning.

Current healthcare-tech news, AI pressure, and sales execution notes from inside the startup-to-$10M valley.

No pitch. No spam. Unsubscribe anytime.